TransAct Technologies Incorporated (TACT)
Official siteTECHNOLOGY • COMPUTER HARDWARE • NASDAQ
Market Cap: $50.07M
Last updated: Nov 17, 2026 at 10:59 AM ET
TransAct Technologies Incorporated (TACT) Financials: Revenue, Profit and Cash Flow
TransAct Technologies reported revenue of $51.48M for the fiscal year ended Dec 31, 2025, up 18.7% from the year before. That year, net income was -$1.24M with a net margin of -2.4%, operating cash flow was $7.67M and free cash flow was $6.06M. The quarter ended Sep 30, 2026 had revenue of $14.44M and net income of -$440.00K.
Revenue and Margins
The operating margin was -2.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $57.23M, a compound annual decline of 1.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $51.48M | +18.7% | 48.6% | -2.7% | -2.4% |
| Dec 2024 | $43.38M | -40.3% | 49.5% | -8.4% | -22.7% |
| Dec 2023 | $72.63M | +24.9% | 52.9% | 7.9% | 6.5% |
| Dec 2022 | $58.14M | +47.6% | 42.0% | -13.2% | -10.2% |
| Dec 2021 | $39.39M | +28.7% | 39.1% | -23.8% | -10.3% |
| Dec 2020 | $30.59M | -33.1% | 42.3% | -26.7% | -18.4% |
| Dec 2019 | $45.75M | -16.2% | 47.9% | 0.7% | 1.1% |
| Dec 2018 | $54.59M | -3.1% | 49.0% | 12.4% | 9.9% |
| Dec 2017 | $56.31M | -1.6% | 47.3% | 12.1% | 5.7% |
| Dec 2016 | $57.23M | N/A | 41.6% | 9.1% | 6.3% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $51.48M | $43.38M | $72.63M | $58.14M | $39.39M | $30.59M | $45.75M | $54.59M | $56.31M | $57.23M |
| Cost of revenue | $26.46M | $21.90M | $34.23M | $33.73M | $24.00M | $17.67M | $23.81M | $27.84M | $29.65M | $33.44M |
| Gross profit | $25.02M | $21.48M | $38.40M | $24.41M | $15.38M | $12.93M | $21.93M | $26.74M | $26.66M | $23.80M |
| Research and development | $6.70M | $6.98M | $9.44M | $8.57M | $7.47M | $5.70M | $4.39M | $4.58M | $4.30M | $4.42M |
| Operating income | -$1.42M | -$3.63M | $5.71M | -$7.68M | -$9.38M | -$8.17M | $343.00K | $6.76M | $6.81M | $5.20M |
| Net income | -$1.24M | -$9.86M | $4.75M | -$5.94M | -$4.04M | -$5.63M | $516.00K | $5.43M | $3.21M | $3.62M |
| EBITDA | -$610.00K | -$2.68M | $7.65M | -$6.36M | -$7.20M | -$6.78M | $1.75M | $7.49M | $7.89M | $6.53M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.44M | $13.95M | $14.41M | $11.45M | $13.18M | $13.80M | $13.05M | $10.23M | $10.87M | $11.60M | $10.69M | $13.27M |
| Gross profit | $6.69M | $7.00M | $7.25M | $5.45M | $6.56M | $6.65M | $6.36M | $4.52M | $5.23M | $6.11M | $5.62M | $6.37M |
| Operating income | -$415.00K | -$54.00K | $771.00K | -$1.16M | $14.00K | -$258.00K | -$15.00K | -$1.05M | -$837.00K | -$438.00K | -$1.30M | -$522.00K |
| Net income | -$440.00K | -$50.00K | $766.00K | -$1.13M | $15.00K | -$143.00K | $19.00K | -$7.96M | -$551.00K | -$319.00K | -$1.04M | -$62.00K |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $3.00M by $17.43M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $44.77M | $44.03M | $54.20M | $51.83M | $50.93M | $42.25M | $36.06M | $34.96M | $33.95M | $32.04M |
| Current assets | $38.81M | $38.36M | $41.00M | $36.13M | $37.14M | $28.18M | $24.91M | $27.04M | $26.36M | $23.17M |
| Cash and equivalents | $20.43M | $14.39M | $12.32M | $7.95M | $19.46M | $10.36M | $4.20M | $4.69M | $5.51M | $2.50M |
| Total liabilities | $13.65M | $13.40M | $14.78M | $17.97M | $11.95M | $12.01M | $10.13M | $7.39M | $7.94M | $7.93M |
| Short-term debt | $3.00M | $3.00M | $2.25M | $2.25M | $0 | $837.00K | $945.00K | N/A | N/A | $19.00K |
| Long-term debt | N/A | N/A | N/A | N/A | N/A | $2.17M | $0 | N/A | $0 | $0 |
| Shareholder equity | $31.12M | $30.63M | $39.41M | $33.86M | $38.98M | $30.24M | $25.93M | $27.57M | $26.01M | $24.11M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $50.54M | $51.02M | $47.89M | $44.77M | $44.98M | $44.55M | $44.16M | $44.03M | $50.50M | $50.36M | $51.92M | $54.48M |
| Total liabilities | $18.06M | $18.35M | $15.60M | $13.65M | $13.21M | $13.26M | $13.22M | $13.40M | $12.15M | $11.84M | $13.35M | $15.07M |
| Cash and equivalents | $20.21M | $19.39M | $18.84M | $20.43M | $20.04M | $17.75M | $14.18M | $14.39M | $11.34M | $11.13M | $10.63M | $12.32M |
| Shareholder equity | $32.48M | $32.67M | $32.29M | $31.12M | $31.78M | $31.29M | $30.94M | $30.63M | $38.35M | $38.53M | $38.57M | $39.41M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 79.0% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.67M | $1.86M | $5.51M | -$12.22M | -$2.51M | -$3.51M | $4.85M | $5.11M | $5.92M | $4.62M |
| Capital expenditures | $1.61M | $322.00K | $901.00K | $1.30M | $1.38M | $744.00K | $1.37M | $1.47M | $985.00K | $608.00K |
| Free cash flow | $6.06M | $1.54M | $4.61M | -$13.52M | -$3.89M | -$4.25M | $3.48M | $3.64M | $4.93M | $4.02M |
| Dividends paid | N/A | N/A | N/A | N/A | N/A | $0 | $2.68M | $2.67M | $2.58M | $2.42M |
| Share repurchases | N/A | N/A | N/A | N/A | $1.01M | $1.06M | $0 | $2.00M | $358.00K | $3.57M |
| Investing cash flow | -$1.61M | -$322.00K | -$901.00K | -$1.30M | $222.00K | -$1.34M | -$2.37M | -$1.47M | -$985.00K | -$600.00K |
| Financing cash flow | -$119.00K | $634.00K | -$87.00K | $2.06M | $11.47M | $11.03M | -$2.90M | -$4.52M | -$1.92M | -$5.96M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.95M | $2.15M | -$946.00K | $609.00K | $3.63M | $3.60M | -$161.00K | $2.39M | $327.00K | $636.00K | -$1.49M | $916.00K |
| Capital expenditures | $1.00M | $1.55M | $560.00K | $170.00K | $1.41M | $19.00K | $10.00K | $11.00K | $68.00K | $137.00K | $106.00K | $113.00K |
| Free cash flow | $951.00K | $605.00K | -$1.51M | $439.00K | $2.22M | $3.58M | -$171.00K | $2.38M | $259.00K | $499.00K | -$1.60M | $803.00K |
Frequently Asked Questions About TACT
What is TransAct Technologies' annual revenue?
TransAct Technologies reported revenue of $51.48M for the fiscal year ended Dec 31, 2025.
How fast is TransAct Technologies' revenue growing?
Revenue was up 18.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -4.0%.
Is TransAct Technologies profitable?
No. TransAct Technologies reported net income of -$1.24M for the fiscal year ended Dec 31, 2025, with a net margin of -2.4%.
How much free cash flow does TACT generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $7.67M minus capital expenditures of $1.61M produced free cash flow of $6.06M.
How much debt does TransAct Technologies have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $3.00M and cash and equivalents of $20.43M.
TACT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors